Supplementary figure 1. Identification of primary cultured astrocytes.
GFAP is a specific marker for astrocytes. The analysis revealed that at least 95% of the cultured cells were GFAP-positive. Bar:20 m.
Supplementary Figure 2
Supplementary figure 2. Verification of OVX status and E2 replacement treatment.
A. Verification of OVX status. The effects of ovary removal and the estrous stage were determined using cytological evaluations of vaginal smears under microscopic examination. The smears of mice in Con group consisted almost exclusively of leukocytes but including several cornified squamous epithelial cells (showed by the white arrow), indicating that these mice were in diestrus. The smears of the OVX mice also consisted of leukocytes, but the number of leukocytes was significantly less than that in Con group, indicating that these mice were also in diestrus. Bar: 20 m. B.
Results of the levels of serum E2. Data are shown as the mean±S.D; *p<0.05 vs. Con group; #p<0.05 vs. OVX group.
Supplementary Figure 3
Supplementary figure 3. rCBF Measurements.
The rCBF was immediately reduced to<10 % of the pre-ischemic baseline after BCCAO and remained constant during the ischemic period in all animals. After the clips were removed, and the rCBF returned to pre-ischemic values within 5 min.
There were no significant differences in the rCBF between the various groups at any time points. 
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